Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study-Reference-Cited by-同舟云学术

Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study

Published:2021-07 Issue: Volume: Page:
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

O'Donnell Megan,Zaya Romsin,Correia Emily,Krishnasamy Shalini,Sahu Joya,Shi Wenyin,Cha Jisun,Alpdogan Seyfettin Onder,Porcu Pierluigi,Nikbakht Neda

Funder

Skin Cancer Foundation

Publisher

Elsevier BV

Subject

Dermatology

Reference32 articles.

1. Retrospective analysis of prognostic factors in 187 cases of transformed mycosis fungoides;Talpur;Clin Lymphoma Myeloma Leuk,2016

2. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis;Vural;Turk J Haematol,2018

3. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas;Willemze;Blood,2019

4. Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases;Benner;Blood,2012

5. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study;Salhany;Am J Pathol,1988

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Skin T-Cell Receptor Diversity in Large Cell Transformed Mycosis Fungoides;Journal of Investigative Dermatology;2023-11

2. Brentuximab vedotin treatment for mycosis fungoides with CD30+ large‐cell transformation in the early stage;Journal of Cutaneous Immunology and Allergy;2023-09-29

3. Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome;Blood;2023-02-16

4. Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives;Annals of Hematology;2022-12-13

5. An Overview of the EORTC-CLTG 2022 Congress;EMJ Oncology;2022-11-14